Current Progress in Biotechnology Seminar: Shelley Force Aldred

Abstract sculptural forms with colorful, translucent panels behind text reading ‘UC Davis Biotechnology Program, Friday Seminars.’

Event Date

Fri, Apr 17, 2026 @ 11:00am - 12:00pm

1022 Green Hall

Green Hall

Dr. Shelley Force Aldred, CEO and Co-Founder, Rondo Therapeutics

Title: Unlocking the Power of Bispecific Antibodies for Treating Solid Tumors

About the Series
The Current Progress in Biotechnology Seminars, also known as "Friday Seminars," bring researchers and trainees together to explore current progress in biotechnology and its applications. Hosted by the UC Davis Biotechnology Program, the series, which has course codes DEB294/ECH 294, supports interdisciplinary exchange, professional development, and preparation for careers in biotechnology and industry.